Advances in Hidradenitis Suppurativa

Multimedia Medical Education

Supported by an educational grant from AbbVie.*
Medical accuracy confirmed at release date.

Recent Advances in Our Understanding and Management of HS: From Mild to Worsening HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Combined Medical and Surgical Approaches in Moderate-to-Severe HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Troubling Cases of HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Ask the Faculty
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Modifying the Impact of HS: Lifestyle Considerations
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Thrasyvoulos Tzellos, MD, MSc, PhD
Release Date: 15 October 2018
Addressing the Psychosocial Symptoms of HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018
Easing the Pain: Approaches for Clinicians Managing HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Falk G. Bechara, MD
Release Date: 15 October 2018
What’s the Goal? Perspectives on What We Want to Achieve for Patients With HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018

Faculty Communications

Case Studies, Literature Reviews, and Survey Results

Highlights from the 6th EHSF Conference in 2017
Kelsey R. van Straalen, MD
Hessel H van der Zee, MD

Join the Discussion
Survey Report: How Do Clinicians Approach the Management of Hidradenitis Suppurativa?
Caitriona Ryan, MD

Join the Discussion
Literature Review: Evaluating the Psychological Burden of HS and Its Impact on Relationships and Sexual Function
Hessel H van der Zee, MD, PhD

Join the Discussion

Patient Case Studies

64-year-old woman with past medical history of psoriasis and alcoholic liver cirrhosis who presented with a diffuse, erythematous,...

32-year-old Caucasian gentleman who developed thyrotoxicosis following the commencement of ustekinumab treatment. Following...

61-year-old patient who initially presented to our hospital with a 2-day history of worsening pain, swelling, and blistering...

See more >>

In the News

AAD Releases First-Ever Guidelines for Treating Paediatric Patients With Psoriasis
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released guidelines to help ensure that paediatric psoriasis patients receive the best possible treatment and care. The joint AAD/NPF guidelines, published in the Journal of the American Academy of...
Psoriasis Appears Associated With Increased Risk of Developing, Dying of Cancer
Patients with psoriasis appear to have an increased risk of cancer incidence and cancer-related mortality, according to a study published in JAMA Dermatology. For the study, Alex Trafford, University of Manchester, Manchester, United Kingdom, and colleagues searched through 6 electronic databases...
Imaging Tests Help Reveal Heart Risks in Patients With Psoriatic Disease
Combining vascular imaging data with information on cardiovascular risk factors may improve the accuracy of cardiovascular risk stratification in patients with psoriatic disease, according to a study published in Arthritis...
See more >>

Conference Reports

Therapeutic Drug Monitoring Does Not Improve Remission Rates in Patients Starting Infliximab Therapy

By Eric Ramos

CHICAGO -- June 9, 2020 -- Therapeutic drug monitoring in patients with rheumatic diseases who are starting treatment with infliximab does not appear to be superior to standard treatment in order to achieve remission, according to a study presented at the 2020 Virtual...

Risankizumab Bests Fumaric Acid Esters for Treatment-Naïve Patients With Plaque Psoriasis in Head-to-Head Trial

By Eric Ramos

MADRID, Spain -- October 13, 2019 -- A head-to-head trial comparing risankizumab (Skyrizi) with oral fumaric acid esters (FAE) for treatment-naïve patients with moderate-to-severe plaque psoriasis has demonstrated the superiority of risankizumab for all studied efficacy...

Higher Systemic Exposure to Crisaborole of Children Versus Adults With Psoriasis Is Unlikely

By Brian Hoyle

CHICAGO -- September 18, 2019 -- The likelihood of children with psoriasis having a higher systemic exposure to crisaborole than adults after topical application is low, according to a study presented here at the 2019 Annual Meeting of the American College of Clinical...

see more >>

Recently Published

Association of previous treatment with anti-tumour necrosis factor inhibitors with the effectiveness of secukinumab in the treatment of psoriatic arthritis: systematic review and meta-analysis
Yantao Xu, Yuting Li, Mengyuan Dong, Zi'ang Gao, Xiang Chen, Hong Liu, Minxue Shen
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through 1 Year in Biologic-naïve Psoriatic Arthritis Patients
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng, Yusang Jiang, Bei Zhou, Yanli Zhuang, Désirée van, der Heijde, Philip J Mease
12-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post-hoc analysis of six randomized trials
Philip Hampton, Anna Halliday, Maher Aassi, Subhashini Subramanian, Minal Jain, Christopher E M Griffiths
See more >>

Full-Text Articles

JAMA Dermatology
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review
Marieke E C van Winden, Lara S van der Schoot, Mariluz van de L'Isle Arias, Lieke J van Vugt, Juul M P A van den Reek, Peter C M van de Kerkhof, Elke M G J de Jong, Satish F K Lubeek
Scientific Reports
Prevalence of sacroiliitis and acute and structural changes on MRI in patients with psoriatic arthritis
Marcio Vale Braga, Samily Cordeiro de Oliveira, Antonio Helder Costa Vasconcelos, Jailson Rodrigues Lopes, Carlos Leite de Macedo Filho, Lysiane Maria Adeodato Ramos, Carlos Ewerton Maia Rodrigues
BMJ Open
Pain associated with psoriasis: systematic scoping review protocol
Ana Sanader Vucemilovic, Danijela Nujic, Livia Puljak
See more >>

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.